Literature DB >> 23528935

mTORC2: actin on your memory.

Sheena A Josselyn, Paul W Frankland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23528935     DOI： 10.1038/nn.3362

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN： 1097-6256            Impact factor:   24.884


× No keyword cloud information.
  14 in total

Review 1.  Structural plasticity and memory.

Authors:  Raphael Lamprecht; Joseph LeDoux
Journal:  Nat Rev Neurosci       Date:  2004-01       Impact factor: 34.870

Review 2.  Upstream and downstream of mTOR.

Authors:  Nissim Hay; Nahum Sonenberg
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

3.  Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas.

Authors:  C B Knobbe; A Trampe-Kieslich; G Reifenberger
Journal:  Neuropathol Appl Neurobiol       Date:  2005-10       Impact factor: 8.090

Review 4.  TOR signaling in growth and metabolism.

Authors:  Stephan Wullschleger; Robbie Loewith; Michael N Hall
Journal:  Cell       Date:  2006-02-10       Impact factor: 41.582

5.  A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus.

Authors:  Shao Jun Tang; Gerald Reis; Hyejin Kang; Anne-Claude Gingras; Nahum Sonenberg; Erin M Schuman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

Review 6.  Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy.

Authors:  Lorenzo A Cingolani; Yukiko Goda
Journal:  Nat Rev Neurosci       Date:  2008-05       Impact factor: 34.870

Review 7.  Gene discovery in Drosophila: new insights for learning and memory.

Authors:  J Dubnau; T Tully
Journal:  Annu Rev Neurosci       Date:  1998       Impact factor: 12.449

8.  Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage.

Authors:  Loredana Stoica; Ping Jun Zhu; Wei Huang; Hongyi Zhou; Sara C Kozma; Mauro Costa-Mattioli
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-09       Impact factor: 11.205

Review 9.  Defining the role of mTOR in cancer.

Authors:  David A Guertin; David M Sabatini
Journal:  Cancer Cell       Date:  2007-07       Impact factor: 31.743

10.  mTORC2 controls actin polymerization required for consolidation of long-term memory.

Authors:  Wei Huang; Ping Jun Zhu; Shixing Zhang; Hongyi Zhou; Loredana Stoica; Mauricio Galiano; Krešimir Krnjević; Gregg Roman; Mauro Costa-Mattioli
Journal:  Nat Neurosci       Date:  2013-03-03       Impact factor: 24.884
View more
  6 in total

1.  LARG GEF and ARHGAP18 orchestrate RhoA activity to control mesenchymal stem cell lineage.

Authors:  William R Thompson; Sherwin S Yen; Gunes Uzer; Zhihui Xie; Buer Sen; Maya Styner; Keith Burridge; Janet Rubin
Journal:  Bone       Date:  2017-12-05       Impact factor: 4.398

2.  Nuclear and membrane estrogen receptor antagonists induce similar mTORC2 activation-reversible changes in synaptic protein expression and actin polymerization in the mouse hippocampus.

Authors:  Fang-Zhou Xing; Yan-Gang Zhao; Yuan-Yuan Zhang; Li He; Ji-Kai Zhao; Meng-Ying Liu; Yan Liu; Ji-Qiang Zhang
Journal:  CNS Neurosci Ther       Date:  2018-01-19       Impact factor: 5.243

3.  Reversal of phenotypes of cellular senescence by pan-mTOR inhibition.

Authors:  Hannah E Walters; Sylwia Deneka-Hannemann; Lynne S Cox
Journal:  Aging (Albany NY)       Date:  2016-02       Impact factor: 5.682

4.  Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors.

Authors:  Charalambos Kaittanis; Chrysafis Andreou; Haley Hieronymus; Ninghui Mao; Catherine A Foss; Matthias Eiber; Gregor Weirich; Palak Panchal; Anuradha Gopalan; Juan Zurita; Samuel Achilefu; Gabriela Chiosis; Vladimir Ponomarev; Markus Schwaiger; Brett S Carver; Martin G Pomper; Jan Grimm
Journal:  J Exp Med       Date:  2017-11-15       Impact factor: 14.307

Review 5.  mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases.

Authors:  Hannah E Walters; Lynne S Cox
Journal:  Int J Mol Sci       Date:  2018-08-08       Impact factor: 5.923

6.  The role of mTOR in age-related diseases.

Authors:  Zofia Chrienova; Eugenie Nepovimova; Kamil Kuca
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.